Protocol
targeted supplementation · supplement prescription · nutraceutical protocol · biomarker-guided supplementation · personalised stack
The bundled offering has no outcome trials. There is no published RCT testing whether biomarker-guided supplement selection, as a strategy, improves mortality, morbidity, or any validated healthspan endpoint versus standard care or versus untargeted supplementation. Correcting a genuine, measured deficiency (vitamin D, B12, iron) is established clinical medicine, but that is deficiency treatment, not life extension, and evidence for supplementing people who are already replete is largely null or in some trials harmful. Individual components differ sharply in support and should not inherit credibility from the testing wrapped around them. The personalisation itself is the unevidenced claim: measuring a marker, acting on it, and remeasuring demonstrates that the marker moved, not that the patient will live longer or better. Notably, Everlab's own article stresses it does not sell or prescribe named products and matches supplements to test results, which is a more restrained framing than the category norm. Graded commercial because the marketing promise (healthspan extension through a personalised stack) substantially exceeds what the evidence base establishes.
Singapore
Australia
What it is
A clinic service in which blood and other biomarker testing is used to select a individualised set of supplements, typically corrections for measured deficiencies (vitamin D, B12, iron, omega-3 index) alongside longevity-branded compounds, with repeat testing to track change. It is a bundled process rather than a single product, and what is actually dispensed varies widely between clinics. It is claimed to slow biological ageing or extend healthspan by correcting individual biochemical shortfalls.
Offered by
Keep reading
Sources
Every entity profile on variis is sourced. Not medical advice.